About: This webinar is presented in Japanese.
Antimicrobial Resistance (AMR) is a critical global challenge that poses serious threats to healthcare systems worldwide. This webinar provides a clear overview of the fundamentals of AMR and outline how the pharmaceutical industry should respond to this pressing issue.
It introduces the Antibiotic Manufacturing Standard developed by the AMR Industry Alliance and highlight emerging certification schemes designed to ensure responsible practices across the industry. In addition, key initiatives led by the SHIONOGI Group will be presented, illustrating the path toward sustainable healthcare.
This session offers a valuable opportunity to deepen your understanding of AMR and explore practical approaches to addressing this global concern.

Speakers

• Kozo Ohashi, EHS Management Group Member, Corporate Governance Department, Shionogi
  Kozo Ohashi has 3 years of experience in EHS management at SHIONOGI, leading responsible manufacturing initiatives for antimicrobial resistance (AMR). He is a member of the AMR Industry Alliance Manufacturing Working Group and previously spent 18 years in clinical development, contributing to new drug research, including antibiotics.
• Wenjia Xu, Associate Director, Global Safety and Environment, MSD, PSCI capability committee co-lead
  Wenjia is an EHS professional with 20 years of experience in chemical and pharmaceutical industries, currently at MSD Global Safety and Environment. He specializes in EHS due diligence for suppliers and projects and has strong expertise in PSCI principles through 8 years of audit and capability-building work.

The slides used in the webinar can be accessed here.

About : This webinar is presented in Mandarin. It decodes the “Three-Step Framework” of the decarbonisation handbook, using seven key impact areas in the pharmaceutical industry—R&D/Clinical, Laboratories, Production & Energy, Supply Chain & Logistics, Packaging, and Green IT—as a guide.
It breaks down the potential, cost, implementation timeline, and regulatory complexity of 24 actionable carbon reduction measures one by one, helping EHS, Procurement, and Operations teams collaboratively develop a localized priority action list. Additionally, it provides an overview of six key organizational capabilities to support implementation from pilot to scale.

Speakers

• Li Liu, Boehringer-Ingelheim, EHS&S Manager
• Thea Zhang, Boehringer-Ingelheim, EHS Supervisor

PSCI China Website link: Toward Net-Zero - Interpreting the PSCI Decarbonization Playbook

About: This webinar is presented in Mandarin and the presentation slides are bilingual in Mandarin/English.
This webinar outlines the market for renewable energy procurement in China and opportunities to progress renewable energy sourcing.

Speakers

• Gary Lu, AstraZeneca APAC, SHE and Sustainability Director
• Christian Romig, Boston Consulting Group, Associate Director.

PSCI China Website link: Renewable Energy Sourcing: Market and Practice

2025 was another year of impact for the PSCI, full of highlights that were made possible by the dedication and expertise of our Members and delivered benefits for Members, suppliers, and ultimately patients across the world.

From projects to partnerships and beyond, the PSCI is the place to be for collaboration across the sector, creating change, impact, and value.

Through the contributions of the Board, Committees, Topic Teams, and Regional Teams, we are shaping the supplier market and delivering our mission of building responsible supply chains.

Watch this video to hear more.

The pharmaceutical sector's Scope 3 emissions from purchased goods and services total over 272 million tCO2-e, representing more than 80% of the industry's carbon footprint. This webinar highlights how suppliers across the pharmaceutical value chain are driving verified, measurable climate impact and helping companies meet rising ESG expectations.

Join James Connelly, CEO of My Green Lab, to deep dive into the tools empowering pharmaceutical suppliers to deliver verified sustainability performance. He will cover the Converge Supplier Initiative, My Green Lab Certification, the ACT RFP Letter, ACT API integration into purchasing platforms, and the ACT Ecolabel for verified claims. James will also share insights from My Green Lab's 2025 Carbon Impact Report, showing how supplier engagement accelerates Scope 3 reductions. Whether you’re a supplier seeking to differentiate or a pharmaceutical company aiming to strengthen supplier collaboration, this session offers actionable pathways to achieve measurable climate results.

The associated slides for this recording can be found here

The commercial and sales teams in the pharmaceutical industry spend a significant amount of time traveling to meet healthcare providers, distributors, and customers across diverse geographies. Road safety is the number one risk in India and road incidents directly impact personal safety, business continuity, and customer engagement.

This session will cover key aspects of road safety including safe driving practices and behaviours, managing fatigue and stress on the road, and the importance of avoiding distractions while driving. Demonstrating leadership in road safety strengthens employee engagement, corporate reputation, supports ESG commitments, and contributes to India’s National Road Safety Mission. By participating, you can help your organizations drive collective action towards a safer, more responsible, and resilient pharmaceutical ecosystem.

Speakers:

Mahesh Chandak

Head of SSHE - South Asia and Global Road Safety Lead, Bayer

Rajani Chavan

SSHE Enablement Lead, South Asia and India Road Safety lead, Bayer

The associated slides can be downloaded here

The PSCI was delighted to exhibit at CPHI Frankfurt 2025 as an Official Sustainability Partner of the conference. We engaged with Members, Supplier Partners, and other Partners all working towards building responsible supply chains.

Check out our highlights video and see you next year at CPHI Milan!